Contribution of tumour necrosis factor α and interleukin (IL) 1β to IL6 production, NF-κB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Issue 9 (24th February 2005)
- Record Type:
- Journal Article
- Title:
- Contribution of tumour necrosis factor α and interleukin (IL) 1β to IL6 production, NF-κB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Issue 9 (24th February 2005)
- Main Title:
- Contribution of tumour necrosis factor α and interleukin (IL) 1β to IL6 production, NF-κB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors
- Authors:
- Chevrel, G
Granet, C
Miossec, P - Abstract:
- Abstract : Objective: To evaluate the effect of tumour necrosis factor α (TNFα), interleukin (IL) 1β, and their respective inhibitors the p75 TNFα soluble receptor (sTNFR) and the type II sIL1βR (sIL1RII) on whole muscle and isolated myoblast activation. Methods: Normal muscle samples were stimulated for 7 days with TNFα alone or in combination with IL1β, and myoblasts from these samples for 48 hours. IL6 production was measured by ELISA. Nuclear translocation of NF-κB was analysed by immunofluorescent staining and class I MHC expression by FACS. Results: TNFα and IL1β induced IL6 production by normal muscle samples and myoblasts, the action of TNFα being more potent on muscle samples. Their soluble receptors (1 μg/ml) decreased this production. Suboptimal concentrations of TNFα and IL1β induced NF-κB translocation. sTNFR markedly down regulated TNFα-induced translocation while sIL1RII was less potent on IL1β-induced activation. NF-κB translocation induced by the combination of optimal concentrations of TNFα and IL1β was completely inhibited by their soluble receptors. TNFα and to a lesser extent IL1β induced class I MHC expression by myoblasts and this effect was completely inhibited by their respective soluble receptors. Conclusion: These results suggest that TNFα and IL1β should be targeted for myositis treatment.
- Is Part Of:
- Annals of the rheumatic diseases. Volume 64:Issue 9(2005)
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 64:Issue 9(2005)
- Issue Display:
- Volume 64, Issue 9 (2005)
- Year:
- 2005
- Volume:
- 64
- Issue:
- 9
- Issue Sort Value:
- 2005-0064-0009-0000
- Page Start:
- 1257
- Page End:
- 1262
- Publication Date:
- 2005-02-24
- Subjects:
- DMEM, Dulbecco's modified Eagle's medium -- ELISA, enzyme linked immunosorbent assay -- FACS, fluorescence activated cell sorter -- FCS, fetal calf serum -- FITC, fluorescein isothiocyanate -- IL1β, interleukin 1β -- IIM, idiopathic inflammatory myopathies -- MHC, major histocompatibility complex -- NF-κB, nuclear factor κB -- PBS, phosphate buffered saline -- RA, rheumatoid arthritis -- sR, soluble receptor(s) -- TNFα, tumour necrosis factor α
interleukin 1 -- myoblasts -- myositis -- soluble receptors -- tumour necrosis factor α
Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/ard.2004.032359 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17702.xml